Life-long Learning Programme for Post-Graduate Biomedical and Pharmaceutical Professionals

Researchers often have a great idea for a new medicine, but the journey from concept to market and patient is complex. The Life-long Learning Programme for post-graduate biomedical and pharmaceutical professionals provides a solution: a modern, post-graduate education and training programme guiding researchers and professionals in the development of new medicines and vaccines. This project was submitted to PharmaNL by the Leiden University Medical Center (LUMC), under the leadership of Marcel Kenter, Director of the Paul Janssen Futurelab.

The three-year project will develop three online courses, including two completely new modules on preclinical research and science-based development strategies, as well as an update of an existing course. Participants will learn, among other things, how to collect essential research data and compile a complete regulatory dossier in preparation for market authorisation.

The programme combines online knowledge transfer with practical assignments, industry case studies, and mentorship from experienced professionals. This creates an inspiring learning experience in which knowledge can be applied directly. Participants can study flexibly, with the programme designed to fit alongside busy professional and personal schedules.

The project targets academics, industry professionals, and regulatory authorities involved in drug development. By feeding pharmaceutical industry knowledge and skills back into the academic world, this initiative helps keep more development within academia, stimulates innovation, and ultimately contributes to affordable medicines for patients.

Objective

To strengthen the knowledge and skills of enterprising researchers, enabling them to effectively develop, register, and bring new medicines or vaccines to market.

“A good idea for a new medicine is only the beginning. We are developing an inspiring post-graduate, learning-by-doing programme to help researchers actually develop, register, and deliver their ideas to patients,” says Marcel Kenter (LUMC).

Read more